These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

59 related items for PubMed ID: 1317243

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26. [CY 222, a very low molecular weight heparin, in the curative treatment of deep venous thrombosis. Apropos of 95 cases. Clinical and phlebographic results].
    Janvier G, Dugrais G, Winnock S, Vergnes C, Boisseau M, Broussin J, Serise JM, Boissieras P, Videau J, Toulemonde F.
    J Mal Vasc; 1987; 12 Suppl B():141-4. PubMed ID: 2834487
    [Abstract] [Full Text] [Related]

  • 27. [Efficacy and tolerance of low molecular weight heparin in the prevention of deep venous thrombosis during non-emergent total hip arthroplasty. A prospective, multicenter trial].
    Simon P, Kindermans A, Kempf JF, Postel M.
    J Chir (Paris); 1990 May; 127(5):252-7. PubMed ID: 2165076
    [Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29. Fragmin once or twice daily subcutaneously in the treatment of deep venous thrombosis of the leg.
    Holmoström M, Berglund MC, Granquist S, Bratt G, Törnebohm E, Lockner D.
    Thromb Res; 1992 Jul 01; 67(1):49-55. PubMed ID: 1332213
    [Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32. [Prevention of deep venous thrombosis of the leg by a very low molecular weight heparin fraction (CY 222) in patients with hemiplegia following cerebral infarction: a randomized pilot study (30 patients)].
    Elias A, Milandre L, Lagrange G, Aillaud MF, Alonzo B, Toulemonde F, Juhan-Vague I, Khalil R, Bayrou B, Serradimigni A.
    Rev Med Interne; 1990 Jul 01; 11(1):95-8. PubMed ID: 2158140
    [Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34. [Implementing ambulatory prevention of thrombosis with low molecular weight heparin in plaster immobilization of the lower extremity].
    Kock HJ, Schmit-Neuerburg KP, Hanke J, Terwort A, Rudofsky G, Hirche H.
    Unfallchirurgie; 1994 Dec 01; 20(6):319-28. PubMed ID: 7871610
    [Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36. An evaluation of the biological response to Fraxiparine, (a low molecular weight heparin) in the healthy individual.
    Freedman MD, Leese P, Prasad R, Hayden D.
    J Clin Pharmacol; 1990 Aug 01; 30(8):720-7. PubMed ID: 2169488
    [Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38. Long-term treatment of acute deep venous thrombosis with low-molecular-weight heparin derivative.
    Vitoux JF, Fiessinger JN, Roncato M, Pernes JM, Brenot P, Aiach M.
    JAMA; 1988 Feb 26; 259(8):1180-1. PubMed ID: 2828702
    [No Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40. [Controlled study on the efficacy of external treatment in surface-near thrombophlebitis].
    Schedel F, Hennemann B, Reindl P.
    Fortschr Med; 1977 Jun 16; 95(23):1557-60. PubMed ID: 69596
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 3.